The Three Main Options: Quick Comparison Wegovy: The Heavyweight Champion for Weight Loss Wegovy contains the highest dose of semaglutide specifically formulated for weight management
Compounded Semaglutide and Tirzepatide: What FDA Status Actually Means for You This section matters more than almost any other in this article - because the FDA status of compounded medications is the one thing most buyers don't fully understand going in, and it's the thing with the most practical consequences for your purchase decision
The actual systemic exposure to the infant approaches zero through two independent mechanisms
Glucagon-like peptide-1 receptor agonists gained approval as drugs to treat diabetes and obesity starting in the 2000s
Decision factors: Weight loss goals: Want maximum weight loss and can tolerate side effects: Tirzepatide (Zepbound) shows ~4% greater weight loss than semaglutide on average Want proven cardiovascular benefits: Semaglutide has demonstrated 20% reduction in major cardiovascular events in the SELECT trial Want to try oral option: Oral semaglutide (Rybelsus) for diabetes, though weight loss is less than injectable Side effect sensitivity: Some people tolerate one better than the other
71.2 lbs on average) Retatrutide 9mg: 26.4% body weight reduction Tirzepatide/Zepbound (Phase 3 comparison, not head-to-head): ~20.9% Semaglutide/Wegovy (Phase 3 comparison, not head-to-head): ~14.9% Placebo: ~2.1% Note: These figures come from separate Phase 3 trials and are not direct head-to-head comparisons
